Skip to main content

CORRECTION article

Front. Oncol., 29 June 2022
Sec. Cancer Molecular Targets and Therapeutics
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.952180

Corrigendum: Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer

This article is a correction to:

  1. Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer

    1. Read original article
Keisuke Okuno,&#x;Keisuke Okuno1,2†Rachana Garg&#x;Rachana Garg1†Yate-Ching YuanYate-Ching Yuan3Masanori TokunagaMasanori Tokunaga2Yusuke KinugasaYusuke Kinugasa2Ajay Goel,*Ajay Goel1,4*
  • 1Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Biomedical Research Center, Monrovia, CA, United States
  • 2Department of Gastrointestinal Surgery, Tokyo Medical and Dental University, Tokyo, Japan
  • 3Translational Bioinformatics, Center for Informatics, City of Hope, Duarte, CA, United States
  • 4City of Hope Comprehensive Cancer Center, Duarte, CA, United States

A Corrigendum on
Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer

By Okuno K, Garg R, Yuan Y-C, Tokunaga M, Kinugasa Y and Goel A (2022). Front. Oncol. 12:855860. doi: 10.3389/fonc.2022.855860

In the published article, there was an error about the source of berberine. A correction has been made to the section of Materials and Methods, “Cell Culture and Materials”, paragraph 1:

“Grape seed-OPCs (VX1 extract, EuroPharma USA, Green Bay, WI) and berberine (Berberine HCL, EuroPharma USA, Green Bay, WI) were dissolved in DMSO”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: colorectal cancer, berberine, oligomeric proanthocyanidins, grape seed extract, synergistic effect, apoptosis, MYB, PI3K-Akt signaling pathway

Citation: Okuno K, Garg R, Yuan Y-C, Tokunaga M, Kinugasa Y and Goel A (2022) Corrigendum: Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer. Front. Oncol. 12:952180. doi: 10.3389/fonc.2022.952180

Received: 24 May 2022; Accepted: 26 May 2022;
Published: 29 June 2022.

Edited and reviewed by:

Shoumin Zhu, University of Miami Health System, United States

Copyright © 2022 Okuno, Garg, Yuan, Tokunaga, Kinugasa and Goel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ajay Goel, ajgoel@coh.org

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.